港股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

抗疫概念

1,339.976

0.000

涨家数：3

跌家数：3

平家数：12

市盈率：- -

高：1,339.976

开：1,339.976

低：1,339.976

收：1,339.976

成交量：- -

成交额：- -

市值：8,961.23亿

流通市值：7,511.13亿

数据加载中...

总览新闻资讯

涨超30%！歌礼制药：减重新药进入临床开发阶段

生物药大时代

开拓药业涨超5%拟折让15.03%发行认购股份筹资用于KX-826 III期临床试验

康希诺生物盘中异动早盘股价大涨5.03%报46.380港元

市场担忧科技估值泡沫，部分资金切换至医药，港股通医疗逆势上涨

大型药商最新业绩比拼！上药、九州通、重药控股...

京东健康绩后涨超6%！第三季度经营盈利同比增超1.25倍

老虎资讯综合

港股异动 | 歌礼制药(01672)涨超5%暂现五连阳歌礼正将ASC36打造为每月一次疗法的基石

《股市简讯》中国京东健康升6.4%，三季度非国际财务报告准则盈利同比增超四成

BBC深度报道:中国如何主导全球电池竞赛——从奥运电动巴士到85%市场份额的崛起之路

京东健康涨超5%

每日经济新闻

一枚稀缺小分子，揭开复星医药新叙事

原研获批五个月，超25家药企抢首仿！

【特约大V】邓声兴：恒指短线有调整压力，二万七关徘徊

中信建投 | 医药大健康本周核心推荐

中信建投证券研究

时迈药业拟赴香港上市；映恩生物治疗恶性实体瘤创新药获批临床丨医药早参

每日经济新闻

医药生物行业研究：CNS系列报告-抗抑郁药：单胺深化与新机制探索并行抗抑郁药市场与新药研发进展几何？

康惠股份追讨2.66亿元业绩补偿款，海思科1类新药获批临床，恒瑞医药二代AR抑制剂新进展，智云健康与京东健康签订服务合作协议

千呼万唤，这个全球龙头的三季报终于来了！又是惊掉下巴的业绩！

新能源正前方

大兴机场临空经济区全球招商伙伴大会释放重磅合作机遇

中国金融信息网

解读新荷花招股书，中药集采将加速重构上市公司的产业价值！

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/hans/stock/BK1515/news?page=5"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1515","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1515\",,,,,undefined,":{"symbol":"BK1515","market":"HK","secType":"PLATE","nameCN":"抗疫概念","latestPrice":1339.9764,"timestamp":1763427648679,"preClose":1339.9764,"halted":0,"volume":0,"delay":0,"changeRate":0,"floatShares":0,"shares":0,"eps":0,"marketStatus":"开市前","change":0,"latestTime":"11-18 09:00:48","open":1339.9764,"high":1339.9764,"low":1339.9764,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1763429400000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1763429400000,1763438400000],[1763442000000,1763452800000]],"pbRate":2.498092,"peRate":26.897138,"turnoverRate":0.004076,"increases":3,"decrements":3,"flats":11,"marketCap":896123257408,"floatMarketCap":751113191232},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1515\",,,,,undefined,":{"symbol":"BK1515","high":1339.9764,"amplitude":0,"preClose":1339.9764,"low":1339.9764,"pbRate":"2.498092","latestPrice":1339.9764,"volume":0,"delay":0,"open":1339.9764,"prevYearClose":787.97723,"prevWeekClose":1353.064,"prevMonthClose":1279.786,"prevQuarterClose":1449.838,"fiveDayClose":1274.952,"twentyDayClose":1357.632,"sixtyDayClose":1397.345,"secType":"PLATE","market":"HK","turnoverRate":0.004076,"peRate":26.897138,"marketCap":896123257408,"floatMarketCap":751113191232,"timestamp":1763427648728,"nameCN":"抗疫概念"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1515\",,,,undefined,":{"bkCode":"BK1515","up":3,"down":3,"flat":12},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1515\",pageSize:20,pageCount:5,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2583577529","title":"涨超30%！歌礼制药：减重新药进入临床开发阶段","url":"https://stock-news.laohu8.com/highlight/detail?id=2583577529","media":"生物药大时代","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583577529?lang=zh_cn&edition=fundamental","pubTime":"2025-11-14 11:28","pubTimestamp":1763090889,"startTime":"0","endTime":"0","summary":"11月13日，歌礼制药发布公告，每月一次的新一代胰淀素受体激动剂ASC36和新一代GLP-1R/GIPR双靶点激动剂ASC35复方制剂已进入临床开发阶段，预计2026年第二季度向美国FDA递交用于治疗肥胖症的新药临床试验申请。在头对头DIO大鼠研究中，ASC36和ASC35复方制剂的减重效果较eloralintide和替尔泊肽复方制剂相对提升约51%。ASC36单药及复方制剂疗法歌礼正将ASC36打造为每月一次疗法的基石，用于治疗包括肥胖在内的心脏代谢疾病。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251114131651a4a0acb8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251114131651a4a0acb8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01672","BK1574","BK1161","01477","BK1191","BK1515"],"gpt_icon":0},{"id":"2583852856","title":"开拓药业涨超5%拟折让15.03%发行认购股份筹资用于KX-826 III期临床试验","url":"https://stock-news.laohu8.com/highlight/detail?id=2583852856","media":"动脉网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583852856?lang=zh_cn&edition=fundamental","pubTime":"2025-11-14 11:24","pubTimestamp":1763090640,"startTime":"0","endTime":"0","summary":"港股开拓药业-B(09939)涨超5%，截至发稿涨幅达5.39%，报2.15港元，成交额554.45万港元。消息面上，开拓药业-B发布公告，2025年11月12日，公司拟向华圆管理咨询(香港)有限公司（中新苏州工业园区创业投资有限公司全资拥有）发行3048.75万股认购股份，每股认购价1.64港元，较最后交易日收市价每股1.93港元折让约15.03%，此次认购事项净筹约4978万港元，资金拟用于集团日常业务的一般营运及KX-826的III期临床试验。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511141135309503a123&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511141135309503a123&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1574","BK1515","09939"],"gpt_icon":0},{"id":"2583452195","title":"康希诺生物盘中异动 早盘股价大涨5.03%报46.380港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2583452195","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583452195?lang=zh_cn&edition=fundamental","pubTime":"2025-11-14 10:40","pubTimestamp":1763088020,"startTime":"0","endTime":"0","summary":"2025年11月14日早盘10时40分，康希诺生物股票出现异动，股价快速拉升5.03%。截至发稿，该股报46.380港元/股，成交量31.94万股，换手率0.24%，振幅5.48%。资金方面，该股资金流入841.66万港元，流出386.004万港元。康希诺生物股票所在的生物技术行业中，整体跌幅为0.07%。其相关个股中，基石药业-B、歌礼制药-B、圣诺医药-B涨幅较大，振幅较大的相关个股有基石药业-B、歌礼制药-B、圣诺医药-B，振幅分别为17.67%、14.96%、14.86%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251114104020a4a06263&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251114104020a4a06263&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","06185","BK1515","BK1191","BK1161"],"gpt_icon":0},{"id":"2583527953","title":"市场担忧科技估值泡沫，部分资金切换至医药，港股通医疗逆势上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2583527953","media":"同壁财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583527953?lang=zh_cn&edition=fundamental","pubTime":"2025-11-14 10:35","pubTimestamp":1763087732,"startTime":"0","endTime":"0","summary":"受海外空头做空英伟达、美联储降息预期降温等多重因素影响，以AI、芯片为代表的科技股热度回落。而随着商保创新药目录推出、集采结果出炉、来凯医药重磅BD交易等密集利好催化，资金重新聚焦创新药，医药也成为AI落地预期的重要领域之一。11月14日早盘，港股通医疗ETF逆势涨超1%，在全市场ETF中涨幅靠前，其重仓股京东健康盘中涨超6%，金斯瑞生物科技、翰森制药、平安好医生等领涨。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251114103617a6f856fa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251114103617a6f856fa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09939","BK1571","BK1574","06618","BK1617","01833","BK1515","BK1219","BK1247","BK1615","BK1161","BK1142","03692"],"gpt_icon":0},{"id":"2583506980","title":"大型药商最新业绩比拼！上药、九州通、重药控股...","url":"https://stock-news.laohu8.com/highlight/detail?id=2583506980","media":"赛柏蓝","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583506980?lang=zh_cn&edition=fundamental","pubTime":"2025-11-14 10:25","pubTimestamp":1763087137,"startTime":"0","endTime":"0","summary":"两家大型药商前三季度营收突破千亿归母净利润有三家前三季度超十亿A股医药流通企业营收排名前十包括：上海医药、九州通、重药控股、国药一致、南京医药、国药股份、中国医药、英特集团、海王生物、鹭燕医药。2025年前三季度营收为622.11亿，同比增长4.22%；归母净利润为3.84亿元，同比增长31.41%。全国龙头药商如上海医药、九州通的业务均覆盖了全国31省/市/自治区。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251114102634a4a05a47&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251114102634a4a05a47&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02607","09939","BK1161","BK1515","BK1197","BK1574"],"gpt_icon":0},{"id":"1162259625","title":"京东健康绩后涨超6%！第三季度经营盈利同比增超1.25倍","url":"https://stock-news.laohu8.com/highlight/detail?id=1162259625","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1162259625?lang=zh_cn&edition=fundamental","pubTime":"2025-11-14 10:23","pubTimestamp":1763086987,"startTime":"0","endTime":"0","summary":"11月14日，$京东健康$绩后涨超6%！第三季度经营盈利同比增超1.25倍 ，与多家知名药企达成战略合作。11月13日，$京东$健康发布2025年第三季度业绩，该集团期内取得收入171.2亿元，同比增加28.7%；经营盈利12.43亿元，同比增加125.3%。2025年9月，京东健康与华中科技大学$同济$医学院附属协和医院完成合作签约，致力于打造全国领先的智慧门诊患者服务平台。","market":"hk","thumbnail":"https://static.tigerbbs.com/e0ede65b6680c765e9fea3680757fcfd","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/e0ede65b6680c765e9fea3680757fcfd"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"5fee5900c798ae12c9a892e90e4e3066","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1591","SGXZ62798434.SGD","SGXZ86797644.SGD","BK1589","BK1142","LU0456827905.SGD","BK1615","86618","BK1515","LU0051755006.USD","06618","BK1247","BK1571","BK1583"],"gpt_icon":1},{"id":"2583478285","title":"港股异动 | 歌礼制药(01672)涨超5%暂现五连阳 歌礼正将ASC36打造为每月一次疗法的基石","url":"https://stock-news.laohu8.com/highlight/detail?id=2583478285","media":"中金财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583478285?lang=zh_cn&edition=fundamental","pubTime":"2025-11-14 10:17","pubTimestamp":1763086623,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，歌礼制药涨超5%暂现五连阳，本周累计涨幅已超30%。截至发稿，涨5.55%，报12.56港元，成交额1819.48万港元。　　消息面上，歌礼制药发布公告，每月一次新一代胰淀素受体激动剂ASC36和每月一次新一代GLP-1R/GIPR双靶点激动剂ASC35复方制剂进入临床开发阶段。歌礼预计将于2026年第二季度向美国FDA递交ASC36和ASC35复方制剂用于治疗肥胖症的新药临床试验申请。歌礼正将ASC36打造为每月一次疗法的基石，用于治疗包括肥胖在内的心脏代谢疾病。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20251114/31795563.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK1515","01672","01477","BK1191","BK1161","BK1574"],"gpt_icon":0},{"id":"2583754219","title":"《股市简讯》中国京东健康升6.4%，三季度非国际财务报告准则盈利同比增超四成","url":"https://stock-news.laohu8.com/highlight/detail?id=2583754219","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583754219?lang=zh_cn&edition=fundamental","pubTime":"2025-11-14 10:12","pubTimestamp":1763086350,"startTime":"0","endTime":"0","summary":"《股市简讯》中国京东健康升6.4%，三季度非国际财务报告准则盈利同比增超四成* 中国互联网医疗健康平台--京东健康6618.HK周五早盘一度升6.4%，三季度非国际财务报告准则盈利同比增超四成。* 同期恒生科技指数.HSTECH盘中跌1.7%。* 京东健康公告称，三季度收入同比增28.7%，非国际财务报告准则盈利同比增42.4%。* 年初迄今，京东健康累计大涨近1.4倍。（完）\n        更多股市简讯请点选CN-CMN-HOT (发稿 崔珠珠；审校 田镧沁) ((zhuzhu.cui@thomsonreuters.com; +86-21-20830048;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251114:nL4T3WQ06M:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1515","SGXZ86797644.SGD","BK1591","LU0051755006.USD","06618","BK1583","BK1571","SGXZ62798434.SGD","86618","BK1615","BK1589","LU0456827905.SGD","BK1142","BK1247"],"gpt_icon":0},{"id":"2583528518","title":"BBC深度报道:中国如何主导全球电池竞赛——从奥运电动巴士到85%市场份额的崛起之路","url":"https://stock-news.laohu8.com/highlight/detail?id=2583528518","media":"储能世界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583528518?lang=zh_cn&edition=fundamental","pubTime":"2025-11-14 10:09","pubTimestamp":1763086158,"startTime":"0","endTime":"0","summary":"2024年,比亚迪超越特斯拉成为全球最大的电动汽车制造商。2025年第一季度,六家中国公司合计占据全球电动汽车电池市场67.5%的份额,凸显了中国在电池技术方面的战略投资和进步。全球扩张与市场主导中国电池企业正在积极拓展全球市场。截至2024年,中国生产了全球约80%的电池产出、近85%的正极材料和超过90%的负极材料。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251114113513a6f875de&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251114113513a6f875de&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2506951792.HKD","LU0511384066.AUD","LU0244354667.USD","LU0039217434.USD","SG9999001226.SGD","LU0979878070.USD","00285","81211","LU0054450605.USD","LU2097828805.USD","LU0359202008.SGD","LU2348774022.SGD","LU2097828557.USD","LU0359201612.USD","SG9999015978.USD","002594","LU1188198961.HKD","LU2360107325.USD","LU0052750758.USD","LU1719994722.HKD","SG9999015952.SGD","LU0417516738.SGD","LU0516423174.USD","LU0819123356.HKD","LU2153592121.USD","HYDD.SI","BK1119","01211","BK1607","LU0259732245.USD","LU0531970944.HKD","LU0588545490.SGD","BK1515","LU0289739343.SGD","LU1868838027.USD","LU0463099449.HKD","BK1582","03750","LU0650527681.SGD","LU1770034418.SGD","LU0269904917.USD","LU0307460666.USD","LU2097828714.EUR","LU1720050803.USD","LU1242518931.SGD","BYDDY","LU0531971595.HKD","BK1522","LU1880383366.USD","LU2097828474.EUR"],"gpt_icon":1},{"id":"2583542464","title":"京东健康涨超5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2583542464","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583542464?lang=zh_cn&edition=fundamental","pubTime":"2025-11-14 10:02","pubTimestamp":1763085742,"startTime":"0","endTime":"0","summary":"每经AI快讯，京东健康(06618.HK)绩后涨超5%，截至发稿，涨5.35%，报67.9港元，成交额2.53亿港元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202511143564563944.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202511143564563944.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1589","86618","BK1615","SGXZ86797644.SGD","BK1515","BK1583","SGXZ62798434.SGD","BK1247","LU0456827905.SGD","BK1591","06618","BK1142","LU0051755006.USD","BK1571"],"gpt_icon":0},{"id":"2583528329","title":"一枚稀缺小分子，揭开复星医药新叙事","url":"https://stock-news.laohu8.com/highlight/detail?id=2583528329","media":"医药魔方","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583528329?lang=zh_cn&edition=fundamental","pubTime":"2025-11-14 09:47","pubTimestamp":1763084865,"startTime":"0","endTime":"0","summary":"复星医药的创新叙事，留下了新的注脚。复星医药传递的故事内核简单而有力——芦沃美替尼以双适应症上市，填补罕见肿瘤疾病治疗空白。以这枚稀缺的小分子为新起点，复星医药更多的创新故事正徐徐展开。一方面，芦沃美替尼现已通过2025年医保目录调整初步形式审查，有望进入2026年国家医保目录。潜在稀缺价值持续叠加复星医药全球研发中心正在通过新适应症开发将芦沃美替尼的创新价值推向更高维度。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251114095720a4a04829&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251114095720a4a04829&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1593","02196","BK1515","BK1191"],"gpt_icon":0},{"id":"2583325528","title":"原研获批五个月，超25家药企抢首仿！","url":"https://stock-news.laohu8.com/highlight/detail?id=2583325528","media":"药融圈","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583325528?lang=zh_cn&edition=fundamental","pubTime":"2025-11-14 09:30","pubTimestamp":1763083856,"startTime":"0","endTime":"0","summary":"摩熵医药数据显示，原研获批不久，国内多家明星药企提交了上市申请。瑞维那新于2020年在国内启动临床申报，2024年完成进口上市申报，并于2025年6月正式获批进入中国市场。截图来源：摩熵医药中国药品批文数据库原研药获批仅7日，倍特药业便于6月19日率先申报瑞维那新吸入溶液4类仿制上市。随后齐鲁制药、科伦制药、复星医药等超25家药企竞相入场角逐首仿。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251114100904a4a0503b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251114100904a4a0503b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09939","BK1191","02196","BK1515","01477","BK1593","BK1574","BK1161"],"gpt_icon":0},{"id":"2583448195","title":"【特约大V】邓声兴：恒指短线有调整压力，二万七关徘徊","url":"https://stock-news.laohu8.com/highlight/detail?id=2583448195","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583448195?lang=zh_cn&edition=fundamental","pubTime":"2025-11-14 09:15","pubTimestamp":1763082920,"startTime":"0","endTime":"0","summary":"恒指短线有调整压力，二万七关徘徊。三生制药2025年中国生物医药企业对外授权交易总额首次突破千亿美元大关，标志着国内创新药企的研发实力已获得国际市场广泛认可，也推动资本市场对具备创新实力的药企重新估值。随着中国创新药持续获得国际市场青睐，三生制药凭藉其扎实的研发管线与成功的国际合作，有望在行业发展浪潮中持续提升其市场价值与竞争地位，为投资者创造长期回报。","market":"fut","thumbnail":"https://static.szfiu.com/news/20241108/NGExMWIwZjY5YWMzZDJiYjI3NzU4NjU1MjcxMDI5NzU=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/NGExMWIwZjY5YWMzZDJiYjI3NzU4NjU1MjcxMDI5NzU=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1969638","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","BK1515","IE00BZ08YS42.EUR","IE00BZ08YT58.USD","01177","HSI","IE00BZ08YR35.GBP","BK1589","HHImain","BK1583","513600","BK1191","BK1237","BK4614","HK0000165453.HKD","YANG","03692","MCHmain","MHImain","02833","06683","HSImain","BK1521","BK1593","01530"],"gpt_icon":0},{"id":"2583526229","title":"中信建投 | 医药大健康本周核心推荐","url":"https://stock-news.laohu8.com/highlight/detail?id=2583526229","media":"中信建投证券研究","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583526229?lang=zh_cn&edition=fundamental","pubTime":"2025-11-14 07:46","pubTimestamp":1763077618,"startTime":"0","endTime":"0","summary":"报告来源证券研究报告名称：《医药行业周度复盘》对外发布时间：2025年11月13日报告发布机构：中信建投证券股份有限公司本报告分析师：贺菊颖 SAC编号：S1440517050001SFC编号：ASZ591袁清慧 SAC编号：S1440520030001SFC编号：BPW879王在存 SAC编号：S1440521070003刘若飞 SAC编号：S1440519080003SFC编号：BVX723汤然 SAC编号：S1440524100001《医疗器械行业周报》本周港股多个创新器械公司回调，与港股整体行情有关，未了解到其他基本面变化；A股医疗器械板块涨跌较多的部分个股预计与事件催化、业绩预期等因素相关。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251114094643a6f838b3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251114094643a6f838b3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1719994722.HKD","LU1251922891.USD","LU0588546209.SGD","BK1574","LU0307460666.USD","06160","LU1303224171.USD","LU1770034418.SGD","BK1588","LU2328871848.SGD","09939","BK1161","BK1500","BK1515","LU1969619763.USD","BK1583"],"gpt_icon":0},{"id":"2583754346","title":"时迈药业拟赴香港上市；映恩生物治疗恶性实体瘤创新药获批临床丨医药早参","url":"https://stock-news.laohu8.com/highlight/detail?id=2583754346","media":"每日经济新闻","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583754346?lang=zh_cn&edition=fundamental","pubTime":"2025-11-14 07:14","pubTimestamp":1763075693,"startTime":"0","endTime":"0","summary":"丨2025年11月14日星期五丨NO.1时迈药业拟赴香港上市港交所官网显示，浙江时迈药业递交上市申请，华泰国际为独家保荐人。据悉，时迈药业成立于2017年，作为下一代T细胞衔接器(TCE)疗法的先驱企业，旨在利用并引导人体免疫系统对抗癌症的下一代免疫疗法，公司已开发下一代先锋疗法遮蔽型TCE，可在肿瘤中被选择性激活，用于治疗实体瘤。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202511143563982352.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202511143563982352.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1574","06978","09939","BK1161","BK1515"],"gpt_icon":0},{"id":"2583527935","title":"医药生物行业研究：CNS系列报告-抗抑郁药：单胺深化与新机制探索并行 抗抑郁药市场与新药研发进展几何？","url":"https://stock-news.laohu8.com/highlight/detail?id=2583527935","media":"西南证券","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583527935?lang=zh_cn&edition=fundamental","pubTime":"2025-11-14 00:00","pubTimestamp":1763049600,"startTime":"0","endTime":"0","summary":"样本放大销售额排名前五的抗抑郁药依次为草酸艾司西酞普兰、阿戈美拉汀、舒肝解郁胶囊、盐酸舍曲林、盐酸曲唑酮。目前中国抗抑郁创新药/微创新药已有一款上市，超二十款获批临床，已进入/即将进入收获期。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251114150129a4a0ddb7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251114150129a4a0ddb7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1008478684.HKD","IE00BZ08YT58.USD","LU0326950275.SGD","LU1226287792.SGD","03692","LU1152091168.USD","LU1813983027.USD","LU1951186391.HKD","LU1226287875.USD","IE00B5MMRT66.SGD","IE00B031HY20.USD","LU1226288170.HKD","LU1807302812.USD","LU1993786604.SGD","LU2039709279.SGD","IE00BZ08YR35.GBP","IE0008368742.USD","06887","BK1191","IE00B543WZ88.USD","LU0072913022.USD","LU0501845795.SGD","IE0008369823.USD","LU1960683339.HKD","BK1515","LU1226288253.USD","LU0315179316.USD","LU0880133367.SGD","01093","LU1152091754.HKD","LU0067412154.USD","BK1521","IE00BZ08YS42.EUR","SG9999004220.SGD","LU1328277881.USD","HK0000165453.HKD","LU1226287529.USD","LU0314109678.HKD","LU0140636845.USD"],"gpt_icon":0},{"id":"2583423519","title":"康惠股份追讨2.66亿元业绩补偿款，海思科1类新药获批临床，恒瑞医药二代AR抑制剂新进展，智云健康与京东健康签订服务合作协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2583423519","media":"谈医说药","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583423519?lang=zh_cn&edition=fundamental","pubTime":"2025-11-13 23:03","pubTimestamp":1763046211,"startTime":"0","endTime":"0","summary":"长春高新：公司子公司长春金赛药业有限责任公司收到美国食品药品监督管理局书面通知，金赛药业注射用GenSci143临床试验申请获得批准。康惠股份：近日公司向咸阳仲裁委员会申请仲裁，要求来新胜支付剩余业绩补偿款2.66亿元。智云健康：公司近日与京东健康股份有限公司订立服务合作协议，旨在拓宽莉芙敏片及其他P2M管线产品的线上销售与服务渠道，为患者提供更便捷的购药体验与专业的全周期健康管理服务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251114000124a49f6def&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251114000124a49f6def&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1591","LU0359202008.SGD","LU2543165471.USD","BK1571","BK1617","SGXZ86797644.SGD","BK1583","01276","86618","LU1023057109.AUD","BK1615","06618","SGXZ62798434.SGD","LU0359201612.USD","BK1589","09955","BK1247","BK1142","BK1191","LU0051755006.USD","LU0456827905.SGD","BK1197","LU0359201885.HKD","BK1515"],"gpt_icon":0},{"id":"2583948590","title":"千呼万唤，这个全球龙头的三季报终于来了！又是惊掉下巴的业绩！","url":"https://stock-news.laohu8.com/highlight/detail?id=2583948590","media":"新能源正前方","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583948590?lang=zh_cn&edition=fundamental","pubTime":"2025-11-13 21:29","pubTimestamp":1763040554,"startTime":"0","endTime":"0","summary":"---------万众期待之下，比亚迪的三季报终于出来了！01比亚迪三季报终于出来了第三季度比亚迪实现归母净利润78.23亿元，同比下降32.60%；扣非后归母净利润68.91亿元，同比降幅达36.65%。受财报影响，第二天比亚迪大幅度低开，最终收跌2.72%。就比如很多人吐槽比亚迪这两年将汉唐大降价参与市场竞争是一个巨大的战略失误，认为此举终结了之前汉唐蓬勃向上的势头，毁掉了比亚迪品牌向上的机会。从这个角度，比亚迪还是有希望的。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251114010233a49f83a7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251114010233a49f83a7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0348827113.USD","LU0588546209.SGD","LU0254981946.USD","LU0359202008.SGD","LU1794554557.SGD","LU0315178854.USD","LU0588545904.SGD","BK1610","LU2778985437.USD","BK1149","LU0516422440.USD","HYDD.SI","BK1119","LU0143863198.USD","LU0084288322.USD","LU2097828474.EUR","SG9999015986.USD","00285","LU0289961442.SGD","LU0531970944.HKD","LU0274383008.USD","LU0463099449.HKD","LU0540923850.HKD","LU0588545490.SGD","LU2360107325.USD","LU1880383440.USD","LU0588545730.USD","002594","LU1242518857.USD","SG9999006597.SGD","81211","LU1242518931.SGD","LU2294711713.HKD","LU2097828805.USD","LU0516423091.SGD","LU1303224171.USD","LU0605514214.HKD","LU2449936058.SGD","01211","LU0143863784.USD","LU2399975544.HKD","LU0828238088.HKD","LU2097828631.EUR","LU0531971595.HKD","BK1515","LU2476274308.USD","LU2097828557.USD","BK1540","LU0039217434.USD","BYDDY"],"gpt_icon":1},{"id":"2583656495","title":"大兴机场临空经济区全球招商伙伴大会释放重磅合作机遇","url":"https://stock-news.laohu8.com/highlight/detail?id=2583656495","media":"中国金融信息网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583656495?lang=zh_cn&edition=fundamental","pubTime":"2025-11-13 19:38","pubTimestamp":1763033880,"startTime":"0","endTime":"0","summary":"11月12日，以“聚全球资源 筑临空生态”为主题的2025第五届大兴机场临空经济区全球招商伙伴大会成功举办，三大临空特色产业服务平台集中亮相，超百万平方米高品质产业空间夯实发展基础，吸引近百家全球知名企业家、投资机构代表齐聚新国门，共赴合作机遇盛宴。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2025-11-13/doc-infxhkcq9956309.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["09939","BK1515","BK1574","BK1161"],"gpt_icon":0},{"id":"2583518840","title":"解读新荷花招股书，中药集采将加速重构上市公司的产业价值！","url":"https://stock-news.laohu8.com/highlight/detail?id=2583518840","media":"诊锁界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583518840?lang=zh_cn&edition=fundamental","pubTime":"2025-11-13 18:31","pubTimestamp":1763029888,"startTime":"0","endTime":"0","summary":"解读“新荷花”最新招股书：增收不增利的挑战新荷花是中国领先的中药饮片生产商，专注于技术难度和监管要求更高的毒性饮片领域，并以此为核心竞争优势。在其最新的招股书中已有答案迹象。但2025年上半年毛利率有所回升至25.2%，结合第二批集采将带来的影响，趋势还需持续观察。新荷花作为行业龙头企业，虽然受集采带来的利润压力，但未来在营收方面还将保持增长。对上市药企而言，在集采","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251113232929a6f760b7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251113232929a6f760b7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","BK1191","00570","BK1606"],"gpt_icon":0}],"pageSize":20,"totalPage":23,"pageCount":5,"totalSize":446,"code":"91000000","status":"200"}]}}